Literature DB >> 11339383

Communication issues in 22q11.2 deletion syndrome: children at risk.

C B Solot1, M Gerdes, R E Kirschner, D M McDonald-McGinn, E Moss, M Woodin, D Aleman, E H Zackai, P P Wang.   

Abstract

PURPOSE: The purpose of this investigation is to describe the communication profile of children with the 22q11.2 deletion syndrome from infancy through school age and to examine the influence of other medical aspects, such as palate anomalies, learning disorders, and cardiac defects of the syndrome to communication.
METHODS: Seventy-nine children were examined using standardized tests of speech and language and perceptual measures of resonance and voice.
RESULTS: Results show significant delay in emergence of speech and language milestones with delay/disorder in speech-language processes persisting into the school aged years, including those children diagnosed with nonverbal learning disabilities. Persistent articulation and resonance disorders were also present, presumed to be related in part to palatal anomalies. No correlation was found between cardiac status, learning disorders, palate anomalies and communication disorders.
CONCLUSION: The need for early identification and management of communication skills is crucial in the care of children with the 22q11.2 deletion.

Entities:  

Mesh:

Year:  2001        PMID: 11339383     DOI: 10.1097/00125817-200101000-00015

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  18 in total

1.  Early language measures associated with later psychosis features in 22q11.2 deletion syndrome.

Authors:  Cynthia B Solot; Tyler M Moore; Terrence Blaine Crowley; Marsha Gerdes; Edward Moss; Daniel E McGinn; Beverly S Emanuel; Elaine H Zackai; Sean Gallagher; Monica E Calkins; Kosha Ruparel; Ruben C Gur; Donna M McDonald-McGinn; Raquel E Gur
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2020-07-27       Impact factor: 3.568

Review 2.  A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: implications for clinical evaluation and treatment.

Authors:  Opal Ousley; Kimberly Rockers; Mary Lynn Dell; Karlene Coleman; Joseph F Cubells
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

Review 3.  22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia.

Authors:  Maria Karayiorgou; Tony J Simon; Joseph A Gogos
Journal:  Nat Rev Neurosci       Date:  2010-06       Impact factor: 34.870

Review 4.  LINE-1 retrotransposons in healthy and diseased human brain.

Authors:  Nicole A Suarez; Angela Macia; Alysson R Muotri
Journal:  Dev Neurobiol       Date:  2017-12-29       Impact factor: 3.964

5.  Age-dependent clinical problems in a Norwegian national survey of patients with the 22q11.2 deletion syndrome.

Authors:  Kari Lima; Ivar Følling; Kristin L Eiklid; Solveig Natvig; Tore G Abrahamsen
Journal:  Eur J Pediatr       Date:  2010-02-26       Impact factor: 3.183

6.  Tbx1: identification of a 22q11.2 gene as a risk factor for autism spectrum disorder in a mouse model.

Authors:  Takeshi Hiramoto; Gina Kang; Go Suzuki; Yasushi Satoh; Raju Kucherlapati; Yasuhiro Watanabe; Noboru Hiroi
Journal:  Hum Mol Genet       Date:  2011-09-09       Impact factor: 6.150

Review 7.  Recent developments in the application of the nonverbal learning disabilities model.

Authors:  Brenna C McDonald
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

Review 8.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

Review 9.  The importance of understanding cognitive trajectories: the case of 22q11.2 deletion syndrome.

Authors:  Ann Swillen
Journal:  Curr Opin Psychiatry       Date:  2016-03       Impact factor: 4.741

Review 10.  Neurodevelopmental outcome in 22q11.2 deletion syndrome and management.

Authors:  Ann Swillen; Edward Moss; Sasja Duijff
Journal:  Am J Med Genet A       Date:  2018-04-25       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.